Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-262-8 | CAS number: 56-23-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Immunotoxicity
Administrative data
Description of key information
Studies in rodents have shown significant suppression of immune function following exposure to CTC, but only at doses well above those causing liver effects.
Key value for chemical safety assessment
Additional information
From ATSDR toxicological profile (2005):
Studies in rodents have shown significant suppression of immune function following exposure to CTC, but only at doses well above those causing liver effects: “suppression of immune function (reductions in IgM antibody-forming cell activity, T-cell activity, lymphocyte counts, or host resistance to bacteria) has been observed in animals exposed short-term to oral doses of CTC higher than those causing liver effects. Studies in rodents have shown significant suppression of immune function following exposure to CTC. Exposure of female mice to CTC orally at 500 mg/kg/day for 7 consecutive days caused suppression of T-cell-dependent humoral responses to sheep red blood cells. Exposure of rats up to 160 mg/kg/day for 10 days by oral gavage did not alter the primary antibody response to SRBC, natural killer cell activity, or cytotoxic T-lymphocyte responses; also, spleen and thymus weights were comparable to controls. In female mice exposed to daily gavage doses between 50 and 500 mg/kg/day for 14 days (sufficient for hepatotoxicity) the T-cell-dependent humoral response to SRBC was suppressed at ≥ 50 mg/kg/day, serum anti-SRBC IgM titers were reduced at 100 mg/kg/day, and the absolute number and percentage of CD4+CD8- T-cells per spleen was reduced at 500 mg/kg/day.
Justification for classification or non-classification
No classification is proposed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
